Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have been assigned a consensus rating of “Hold” from the seven research firms that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating on the company.
Several analysts recently weighed in on SAUHY shares. Citigroup reissued a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. BMO Capital Markets initiated coverage on shares of Straumann in a research note on Wednesday, July 8th. They issued an “outperform” rating on the stock. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Straumann in a research report on Tuesday, June 30th. Finally, Barclays reissued an “overweight” rating on shares of Straumann in a report on Thursday, June 18th.
Read Our Latest Stock Analysis on Straumann
Straumann Stock Performance
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Further Reading
- Five stocks we like better than Straumann
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
